Safety of 3-year raloxifene treatment in Japanese postmenopausal women aged 75 years or older with osteoporosis: a postmarketing surveillance study

Menopause : the Journal of the North American Menopause Society
Yasuhiro TakeuchiHideaki Sowa

Abstract

Long-term safety of medication is a concern for older persons because they may have several comorbidities that can influence drug metabolism, efficacy, and safety. In Japan, raloxifene is an effective and well-tolerated medication for the treatment of osteoporosis in postmenopausal women, but there is little available evidence on whether raloxifene has an acceptable safety profile in older women. The objective of this post hoc analysis was to investigate the safety of raloxifene as a long-term treatment of osteoporosis in Japanese postmenopausal women aged 75 years or older. We report a post hoc analysis of a safety dataset (6,960 participants) from a published postmarketing surveillance study (postmenopausal women treated with raloxifene 60 mg/d for ≤3 y). The safety dataset was divided into two groups: (1) women younger than 75 years at baseline (4,522 participants) and (2) women aged 75 years or older at baseline (2,438 participants). Incidence of adverse drug reactions and reactions of note in each age group were compared using Fisher's exact test. Approximately 10% of women in each group reported at least one adverse drug reaction. This analysis did not identify any clinically important differences in the incidence or type...Continue Reading

References

Oct 31, 2001·Journal of Bone and Mineral Metabolism·H OrimoH Kishimoto
Aug 6, 2002·The Journal of Clinical Endocrinology and Metabolism·Pierre D DelmasUNKNOWN Mulitple Outcomes of Raloxifene Evaluation Investigators
Oct 2, 2004·Obstetrics and Gynecology·Deborah GradyUNKNOWN Multiple Outcomes of Raloxifene Evaluation Investigators
Aug 2, 2005·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Ethel S SirisUNKNOWN Continuing Outcomes Relevant to Evista (CORE) Investigators
Apr 18, 2006·Seminars in Arthritis and Rheumatism·L GiangregorioJ D Adachi
Dec 4, 2008·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Richard EastellClaus C Glüer
Mar 18, 2010·Archives of Osteoporosis·Kristina Johnell, Johan Fastbom
Nov 9, 2010·Annual Review of Medicine·Barbara C Silva, John P Bilezikian
Apr 3, 2012·The Journal of Clinical Endocrinology and Metabolism·Mohammad Hassan MuradVictor M Montori
May 11, 2012·The New England Journal of Medicine·Marcea WhitakerGeorge Benson
Jul 4, 2012·Journal of Bone and Mineral Metabolism·Noriko IikuniHideaki Sowa
Dec 4, 2012·Archives of Osteoporosis·Hajime OrimoSaeko Fujiwara
Jan 15, 2013·The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists·Rebecca L DunnMark A Stratton
Jul 6, 2013·Calcified Tissue International·Ding-Cheng ChanRong-Sen Yang

❮ Previous
Next ❯

Citations

Jan 19, 2019·Cancer Causes & Control : CCC·Schelomo MarmorTodd M Tuttle
Apr 13, 2021·Pharmaceutical Patent Analyst·Hai-Long Zhang, Yiqian Li

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Menopause : the Journal of the North American Menopause Society
Etsuro Hamaya, Hideaki Sowa
The Israel Medical Association Journal : IMAJ
S Shani
Menopause : the Journal of the North American Menopause Society
Hisashi UrushiharaAkimitsu Miyauchi
© 2022 Meta ULC. All rights reserved